Clinical Trial Update: A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine [Phase 3]

View source ↗

Summary

A Phase 3 trial is recruiting to evaluate the efficacy, safety, tolerability, and pharmacokinetics of Relutrigine for Developmental and Epileptic Encephalopathy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Developmental and Epileptic Encephalopathy

Drugs mentioned

• Relutrigine (Relutrigine)

Snippet

Sponsor: Praxis Precision Medicines | Conditions: Developmental and Epileptic Encephalopathy 1 | Phase 3 | Status: RECRUITING